| Literature DB >> 34120420 |
Christa Soekamto1, Edward R Chu1, Daniel A Johnson1, Jeong-Hyeon Sohn1, Sepehr Bahadorani1.
Abstract
PURPOSE: Visual impairment from retinal re-detachment could be debilitating. The aim of this review is to evaluate the role of 360° laser retinopexy on success rate of rhegmatogenous retinal detachment (RRD) repair by a meta-analysis study.Entities:
Keywords: Lasers; Meta-analysis; Retinal detachment
Year: 2021 PMID: 34120420 PMCID: PMC8200595 DOI: 10.3341/kjo.2021.0013
Source DB: PubMed Journal: Korean J Ophthalmol ISSN: 1011-8942
Fig. 1Preferred reporting items for systematic review and meta-analysis (PRISMA) flow chart of literature review. RRD = rhegmatogenous retinal detachment.
Characteristics of studies included in meta-analysis
| Study and design | Inclusion criteria | Exclusion criteria | Intervention and no. of participants | Tamponade and follow-up periods (mon) | Single operation attachment rate and percentage (treatment vs. control) | Preoperative logMAR BCVA (treatment vs. control) | Final logMAR BCVA (treatment vs. control) |
|---|---|---|---|---|---|---|---|
| Bilgin et al. (2019) [ | RRD | Pediatric patients, PVR grade C or worse, giant tear, retinal dialysis, eye trauma and traumatic RRD, proliferative diabetic retinopathy, stiffness of the retina and the need for retinectomy, and a follow-up less than 3 months | 23-gauge PPV with 360 laser retinopexy (n = 25) vs. localized to tears (n = 25). Total n = 50 | Gas (SF6 or C3F8) or 1000cSt silicone oil; 1 and 3 months | 24/25 (96.0%) vs. 21/25 (84.0%) | 1.26 vs. 1.19 | 0.52 vs. 0.77 |
| Dirani et al. (2020) [ | RRD | Combined scleral buckling, previously failed retinal procedures, giant retinal tears, history of trauma, PVR (grade C1 or more), macular diseases, vitreous opacities, and diabetic retinopathy | 23-gauge PPV +/− phacoemulsification. 360° laser retinopexy (n = 65) vs. localized to breaks, holes, lattice (n = 86). Total n = 151 | Gas (SF6 or C3F8); 3 months and beyond | 61/65 (93.8%) vs. 70/86 (81.4%) for 3-month follow-up | NA | NA |
| Falkner-Radler et al. (2015) [ | Primary RRD; mild and/or moderate PVR (grades A or B) | Previous RD surgery except for prior laser treatment, previous pneumatic retinopexy, non‐primary RD (secondary to severe globe injuries, infection or tumor), severe PVR (PVR grade C) | 20-gauge PPV +/− phacoemulsification with 360 endolaser (n = 30) vs. 20 G PPV +/− phaco with scleral buckle and localized laser to tears (n = 30). Total n = 60 | Gas or silicone oil; 6 months and beyond | 28/30 (93.3%) vs. 28/30 (93.3%) at final follow-up | 0.72 ± 0.48 vs. 0.88 ± 0.41 | 0.31 ± 0.36 vs. 0.47 ± 0.34 |
| Iwase et al. (2013) [ | RRD | Previous ocular surgery, giant tears, retinal dialysis, trauma, proliferative vitreoretinopathy (PVR, grade C or higher), retinal detachment with macular hole (high myopia), or round hole detachment with no associated PVD | 20-gauge phacovitrectomy with 360 laser (n = 108) vs. laser to breaks (n = 270). Total n = 378. | Air or 20% SF6; 12 months | 106/108 (98.1%) vs. 254/270 (94.1%) | 0.63 ± 0.86 vs. 0.59 ± 0.91 | 0.11 ± 0.26 vs. 0.07 ± 0.29 |
| Loiudice et al. (2021) [ | RRD | Prior vitreoretinal surgery, RRD caused by giant retinal tears, undetected retinal breaks after either dynamic scleral depression or scrupulous vitreous base dissection, PVR grade C or worse and ocular disorders that could interfere with visual recovery (e.g., age-related macular degeneration, diabetic retinopathy, glaucoma) | 23-gauge PPV +/− phacoemulsifica-tion with 360 laser retinopexy (n = 48) vs. laser to breaks or areas of degeneration (n = 45). Total n = 93. | Air; 6 months | 43/48 (89.6%) vs. 39/45 (86.7%) | NA | 0.05 ± 0.03 vs. 0.06 ± 0.05 ( |
| Wang et al. (2020) [ | RRD | Complex retinal detachments, including recurrent detachments, those secondary to trauma, proliferative diabetic retinopathy, sickle cell retinopathy, retinopathy of prematurity, and other retinopathies/vitreoretinopath-ies or those secondary to inflammatory or infectious diseases such as acute retinal necrosis or endophthalmitis, were excluded. Eyes with fewer than three monthsof postoperative follow-up were excluded, as were eyes where the 360-laser variable was not recorded. | 20, 23, 25, or 27-gauge PPV with or without scleral buckle with 360 laser (n = 516) vs. localized laser (n = 1,732). Total n = 2,248 | Air, SF6 or C3F8 gas, or silicone oil; average of 12 ± 6 months | 402/516 (77.9%) vs. 1,334/1,732 (77%) | 1.3 ± 1.1 vs. 1.1 ± 1.1 | 0.56 ± 0.72 vs. 0.43 ± 0.59 |
Treatment group refers to 360° laser versus localized photocoagulation as a control.
logMAR = logarithm of the minimum angle of resolution; BCVA = best-corrected visual acuity; RRD = rhegmatogenous retinal detachment; PPV = pars plana vitrectomy; PVR = proliferative vitreoretinopathy; NA = not applicable; RD = retinal detachment; PVD = posterior vitreous detachment.
Fig. 2Risk of bias in selected randomized studies is demonstrated as low (“+” symbol), high (“−” symbol), or unclear (“?” symbol) in each domain.
Fig. 3Forest plot of the effects of 360° laser retinopexy (“Experimental”) versus localized laser (“Control”) on initial rate of retinal attachment and best-corrected visual acuity (BCVA) in patients undergoing repair of a rhegmatogenous retinal detachment. (A) Attachment rate in all studies, (B) attachment rate in randomized studies, (C) BCVA in all studies, and (D) BCVA in randomized studies. M-H = Mantel-Haenszel; CI = confidence interval; SD = standard deviation; IV = inverse variance; Random = random-effect model.
Fig. 4Sub-group Forest plot of the effects of 360° laser retinopexy (“Experimental”) versus localized laser (“Control”) on initial rate of retinal attachment in patients undergoing repair of a rhegmatogenous retinal detachment with 23-gauge pars plana vitrectomy. M-H = Mantel-Haenszel; CI = confidence interval.